Silencing of p21-activated kinase attenuates vimentin phosphorylation on Ser-56 and reorientation of the vimentin network during stimulation of smooth muscle cells by 5-hydroxytryptamine.
about
The Serine/threonine kinase Stk33 exhibits autophosphorylation and phosphorylates the intermediate filament protein VimentinThe cellular distribution of serotonin transporter is impeded on serotonin-altered vimentin networkCritical role of actin-associated proteins in smooth muscle contraction, cell proliferation, airway hyperresponsiveness and airway remodelingSerotonin: a different player in hypertension-associated thrombosisThe role of mechanotransduction on vascular smooth muscle myocytes' [corrected] cytoskeleton and contractile functionVimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesAbl silencing inhibits CAS-mediated process and constriction in resistance arteriesThe serine/threonine kinase 33 is present and expressed in palaeognath birds but has become a unitary pseudogene in neognaths about 100 million years agoVimentin intermediate filaments modulate the motility of mitochondriaVimentin is involved in regulation of mitochondrial motility and membrane potential by Rac1.c-Abl tyrosine kinase regulates cytokinesis of human airway smooth muscle cells.Histone deacetylase 8 regulates cortactin deacetylation and contraction in smooth muscle tissues.Regulation of vimentin intermediate filaments in endothelial cells by hypoxia.Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels.Glia maturation factor-γ phosphorylation at Tyr-104 regulates actin dynamics and contraction in human airway smooth muscleCommunication between 5-HT and small GTPases.Emergence of airway smooth muscle functions related to structural malleabilityRole of vimentin in smooth muscle force development.Critical role of vimentin phosphorylation at Ser-56 by p21-activated kinase in vimentin cytoskeleton signaling.Cell death induced by the Jak2 inhibitor, G6, correlates with cleavage of vimentin filaments.The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ)Dissociation of Crk-associated substrate from the vimentin network is regulated by p21-activated kinase on ACh activation of airway smooth muscle.Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.Abl regulates smooth muscle cell proliferation by modulating actin dynamics and ERK1/2 activation.p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer.Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeabilityPhysiologic properties and regulation of the actin cytoskeleton in vascular smooth muscleIntermediate filaments in smooth muscle.Raf-1, actin dynamics, and abelson tyrosine kinase in human airway smooth muscle cellsApplying a targeted label-free approach using LC-MS AMT tags to evaluate changes in protein phosphorylation following phosphatase inhibition.Ultrastructural basis of airway smooth muscle contraction.Role of the adapter protein Abi1 in actin-associated signaling and smooth muscle contractionIdentification of cyclins A1, E1 and vimentin as downstream targets of heme oxygenase-1 in vascular endothelial growth factor-mediated angiogenesis.Vimentin dephosphorylation at ser-56 is regulated by type 1 protein phosphatase in smooth muscleProviding cellular signposts--post-translational modifications of intermediate filaments.Abl activation regulates the dissociation of CAS from cytoskeletal vimentin by modulating CAS phosphorylation in smooth muscle.p130 Crk-associated substrate (CAS) in vascular smooth muscle.Cdc42GAP, reactive oxygen species, and the vimentin networkAbl knockout differentially affects p130 Crk-associated substrate, vinculin, and paxillin in blood vessels of micePak protein kinases and their role in cancer.
P2860
Q24315125-204E7FD2-92FB-45BE-9181-BB26ED762F65Q24318954-B290DA80-0729-4F3E-A7B0-27904121521DQ26777713-59A75A91-4117-4C15-8190-E9B2246B034EQ27022328-44AB9F3B-BE4E-46A3-B275-1FACA7C0391BQ27026682-F8E894D5-1FD1-46BE-969F-EC0E791BD17BQ28473693-D396E8CB-405C-433E-8644-BC2781D794BBQ28565734-C2570833-56A1-44EF-887A-E64AB3FAD992Q28646755-2BF905F1-CD60-44AE-B510-B4B8DE112313Q30502005-8500EF91-24F7-4999-9F8C-60B54A185413Q30669131-FB59BDD1-2D8F-4FCB-8340-0BC3F649F288Q33799554-8F6DEDEE-69E9-48ED-B368-05AA174A1AAAQ34001361-181BDD6B-0E19-47D0-A624-3BD5800D9C46Q34085642-F39C83A9-B69E-4E10-BA8B-2BE3A97C3764Q34248836-4B67FDD8-FB5C-433D-8511-C05A2A3C9201Q34471253-ADBCF418-0DE0-4513-B302-887806F71A99Q34777833-1427AD6F-1858-42E0-9F34-AF2FFB1C8BADQ34785093-F8A0FE64-A62C-4762-9E61-C6AC9FA5A583Q34973630-7F08CCDB-7CE3-48CB-B74D-B757D2E754A0Q35126967-D2193692-442A-4250-8B5F-8D4B18C95E58Q35201333-CD88DE9A-3690-4BAE-B5C9-B66AA8FEF40DQ35561072-67795ECD-CADB-4F1B-8A5A-EB238068B94EQ35585558-7B6F3457-F6E0-4BE4-872B-D2A7D0CEE300Q35669749-43BA4D3D-BA01-4FD7-BE21-8CAB41F07261Q35900727-22523ABD-395F-4374-838F-9E79A2499BF9Q36528197-FEEB8222-BF5F-4160-BE68-20E8CF059E3EQ36666494-966E2627-C829-411F-B364-154AED3DE1ECQ36677467-68DA283A-F4F0-4A44-A5B8-D3006B05E83CQ36681278-2037137F-360E-48E7-9F47-1EE7DF9952CCQ36703905-2B9F6B95-9078-41CF-A2C3-E1551A3F02F4Q36837717-5131D8BD-94AC-4CAA-B470-0156A98FF082Q36933205-B968077E-466D-4963-A64E-D4E17F892B26Q37012542-FDF7CB91-AC15-411F-A1B9-8717852EB42CQ37076510-35475F4C-1F5B-4D66-BD52-8B61B0A6BD97Q37125874-2F47CA5D-9A14-4E57-A446-D6CF063B42D5Q37172708-F95FBBC7-AC05-4A54-8BDF-B29ACC52F854Q37175445-3DF73117-825C-4F9A-8C58-252931133128Q37219520-F61699DC-8CBA-42CA-B6DC-E9D96892318AQ37298007-0D07AE36-5ACC-40C9-9D4F-F62667E30F75Q37298295-DFAD8D8D-01A4-4C6B-BF08-639508736C34Q37376062-A546C3C5-5C84-4FE6-868B-F52F764A318F
P2860
Silencing of p21-activated kinase attenuates vimentin phosphorylation on Ser-56 and reorientation of the vimentin network during stimulation of smooth muscle cells by 5-hydroxytryptamine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Silencing of p21-activated kin ...... cells by 5-hydroxytryptamine.
@en
Silencing of p21-activated kin ...... cells by 5-hydroxytryptamine.
@nl
type
label
Silencing of p21-activated kin ...... cells by 5-hydroxytryptamine.
@en
Silencing of p21-activated kin ...... cells by 5-hydroxytryptamine.
@nl
prefLabel
Silencing of p21-activated kin ...... cells by 5-hydroxytryptamine.
@en
Silencing of p21-activated kin ...... cells by 5-hydroxytryptamine.
@nl
P2860
P356
P1433
P1476
Silencing of p21-activated kin ...... e cells by 5-hydroxytryptamine
@en
P2093
P2860
P304
P356
10.1042/BJ20050065
P407
P577
2005-06-01T00:00:00Z